Skip to main content

Formulate

Find pharma jobs. Prep for interviews like no one else can.

Browse

Jobs Companies Drugs Indications Career Advisor About

Insider Intel

Intelligence Hub Therapeutic Areas Contribute Intro Network Salary Explorer For Employers

Legal

Privacy Policy Terms of Service About Our Crawler Content Removal Your Privacy Choices

© 2026 Formulate. Pharma Jobs with Drug Intelligence.

argenx Jobs | Formulate

Jobs
argenx

argenx Jobs

Belgium - Zwijnaarde

Biotechnology

argenx is a life sciences company focused on Antibody therapies.

47 open positions at argenx

View Full Profile

Filters:Immunology ×

Biostatistics Director - Indication Lead

argenx

Posted 2mo ago

Remote

$212K - $292K

Full-time

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

RemoteData ScienceImmunologySenior

H-1B · 1 FY23

Associate Director, Ethics & Compliance - Risk Assessment and Monitoring

argenx

Posted 3mo ago

Remote

$172K - $237K

Full-time

Medical Science Liaison, (San Paulo, Brazil)

argenx

Posted 3mo ago

Brazil - Field

Full-time

Medical AffairsImmunology

Legal Counsel, Germany

argenx

Posted 3mo ago

Remote

Full-time

Clinical Operations Development Lead

argenx

Posted 4mo ago

Remote

$212K - $292K

Full-time

Associate Director Field Based Market Access, Germany

argenx

Posted 8mo ago

Germany - Field

Full-time

(Associate) Director, Patient Advocacy and Public Policy Germany

argenx

Posted 1y ago

Remote

Full-time

Remote

Previous
1
2
3

Company Overview

Active Jobs

50

Pipeline Programs

86

Drug Products

2

Clinical Trials

83

View Full Company Profile

Therapeutic Areas

Neurology Immunology Oncology

Links

Company Website Careers Page

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

RemoteLegalImmunologyEntry

H-1B · 1 FY23

MID

H-1B · 1 FY23

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

RemoteLegalImmunologyMID

H-1B · 1 FY23

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

RemoteClinical OperationsImmunologySenior

H-1B · 1 FY23

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

CommercialImmunologyEntry

H-1B · 1 FY23

Government Affairs

Immunology

Entry

H-1B · 1 FY23